CA1175741A - Composition and method for the treatment of cancer - Google Patents

Composition and method for the treatment of cancer

Info

Publication number
CA1175741A
CA1175741A CA000388472A CA388472A CA1175741A CA 1175741 A CA1175741 A CA 1175741A CA 000388472 A CA000388472 A CA 000388472A CA 388472 A CA388472 A CA 388472A CA 1175741 A CA1175741 A CA 1175741A
Authority
CA
Canada
Prior art keywords
brain tissue
mammal
tissue
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000388472A
Other languages
English (en)
French (fr)
Inventor
Daniel Marban-De La Torre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1175741A publication Critical patent/CA1175741A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA000388472A 1980-05-01 1981-10-22 Composition and method for the treatment of cancer Expired CA1175741A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14541980A 1980-05-01 1980-05-01

Publications (1)

Publication Number Publication Date
CA1175741A true CA1175741A (en) 1984-10-09

Family

ID=22513026

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000388472A Expired CA1175741A (en) 1980-05-01 1981-10-22 Composition and method for the treatment of cancer

Country Status (8)

Country Link
JP (1) JPS5874615A (es)
CA (1) CA1175741A (es)
CH (1) CH655659B (es)
DE (1) DE3116733A1 (es)
ES (1) ES8300477A1 (es)
FR (1) FR2481602A1 (es)
GB (1) GB2075988B (es)
MX (1) MX6826E (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2717227A (en) * 1954-12-22 1955-09-06 Helen L Dawson Composition containing nerve tissue extract and process of producing such extract
DE1095464B (de) * 1956-05-22 1960-12-22 Univ Tulane Verfahren zur Herstellung eines Heilmittels zur Behandlung von Schizophrenie und anderen Geisteskrankheiten

Also Published As

Publication number Publication date
CH655659B (es) 1986-05-15
FR2481602A1 (fr) 1981-11-06
ES501835A0 (es) 1982-11-01
ES8300477A1 (es) 1982-11-01
GB2075988A (en) 1981-11-25
GB2075988B (en) 1983-09-01
DE3116733A1 (de) 1982-04-01
MX6826E (es) 1986-08-08
JPS5874615A (ja) 1983-05-06
FR2481602B1 (es) 1984-06-01

Similar Documents

Publication Publication Date Title
Buinauskas et al. Role of operative stress on the resistance of the experimental animal to inoculated cancer cells
Kilham et al. Viral etiology of spontaneous ataxia of cats.
Hume et al. The homotransplantation of kidneys and of fetal liver and spleen after total body irradiation
JPS6160049B2 (es)
Mann et al. Metabolism of glycerol, sorbitol and related compounds by spermatozoa
Friedemann et al. Investigations on the pathogenesis of tetanus III
JPS6121A (ja) ワクチンおよびその製造法
US4559228A (en) Composition and method for the treatment of cancer
CH657376A5 (en) Process for the preparation of gamma-globulin for intravenous injection
Alexander et al. Adoptively transferred tumor-infiltrating lymphocytes can cure established metastatic tumor in mice and persist long-term in vivo as functional memory T lymphocytes
CA1175741A (en) Composition and method for the treatment of cancer
US4728511A (en) Composition and method for the treatment of cancer
DE3011461A1 (de) Verwendung von propionibakterien
DE2200376A1 (de) Vaccine gegen Streptococcus equi. und Verfahren zu deren Herstellung
DE3539775A1 (de) Neues lymphokin, gegen dieses lymphokin spezifische antikoerper, verfahren zu ihrer herstellung und ihre verwendung
Meuwissen et al. Suppression of graft versus host reaction by mitomycin C
Torrey et al. The treatment of Flexner-Jobling rat carcinomas with bacterial proteolytic ferments
US5516754A (en) Method for the selective dissolution of cancer cells using a composition derived from the photosynthetic system of plants and mammalian embryonic tissue
WO1981001367A1 (en) A water soluble fraction capable of controlling the immune reactions of a host against allogeneic cells or tissue,the pharmaceutical compositions containing said fraction and a process for preparing the latter
DE1617886A1 (de) Verfahren zur Herstellung von Arzneimitteln mit selektivem Tropismus gegen Krebs und bestimmte Organe
Seller Serotonin as a Teratogen
DE3249946C2 (de) hTNF-haltiges therapeutisches Mittel gegen maligne Tumoren und dessen Verwendung
Piller The influence of coumarin on blood levels of radio labelled protein and radio labelled poly-vinyl-pyrrolidone in thermally injured rats
Butler Jr et al. Biologic effects of specific antibodies in reversing the pharmacologic and toxic effects of digoxin
Dick et al. A streptococcus producing symptoms of chorea in a dog

Legal Events

Date Code Title Description
MKEC Expiry (correction)
MKEX Expiry